Skip to main content


Rochester Institute of Technology, University of Rochester Medical Center, and Casana Partner for Inconspicuous Daily Monitoring Study

Rochester Institute of Technology (RIT), the University of Rochester Medical Center (URMC) and Casana have partnered to conduct a research study titled, “Inconspicuous Daily Monitoring to Reduce Heart Failure Hospitalizations”.

Learn More

Casana’s Smart Integrated Technologies Lab (SIT Lab) Cardiovascular Monitoring Toilet Seat (The Heart Seat) Study

This study is an observational study that will be comparing the physiological measures obtained with the Heart Seat against gold standard sensors during a single measurement session. Participants will be requested to visit the Rochester SIT Lab of Casana for the study and will be compensated according to which non-invasive procedures they sign up for.

Learn More

Casana’s In-home Cardiovascular Monitoring Toilet Seat (The Heart Seat) Early User Experience Study

Casana has launched our in-home research study formally titled “In-home cardiovascular monitoring toilet seat (The Heart Seat™) early user experience study.” The goal of this early in-home observational study is to test and refine the user’s experience of utilizing The Heart Seat health monitoring device, which has been built into a toilet seat, called The Heart Seat. Users’ perception of The Heart Seat in concept will be measured, and their experience physically interacting with The Heart Seat will be evaluated.

Learn More


In partnership with UMass Chan Medical School’s Program in Digital Medicine, this study will test how a smart toilet seat can help patients with chronic diseases better manage their health.

Learn More


Nontraditional Electrocardiogram and Algorithms for Inconspicuous In-Home Monitoring: Comparative Study

Casana has been devoted to the study and development of effortless, noninvasive, in-home monitoring since our very conception. The feasibility of Casana’s first product, The Heart Seat, has been tested in a number of studies, one of which is a study comparing the single-lead ECG measured by the seat to a clinical-grade 12-lead ECG. Nontraditional Electrocardiogram and Algorithms for Inconspicuous In-Home Monitoring: Comparative Study was published in a peer-reviewed journal and was authored by our Chief Scientific Officer, Nicholas J Conn PhD, our Head of R&D David A Borkholder PhD, and Karl Q Schwarz MD (affiliated with University of Rochester Medical Center).

Learn More

In-Home Cardiovascular Monitoring System for Heart Failure: Comparative Study

The study, In-Home Cardiovascular Monitoring System for Heart Failure: Comparative Study, authored by Nicholas J Conn PhD., Karl Q Schwarz MD., and David A Borkholder PhD., was inspired by the demand for solutions that can monitor heart failure patients in the home, and reduce hospitalization rates, as health care costs rise.

Learn More

University of Florida, The Villages, and Casana Partner for The Heart Seat Adherence Study

The University of Florida (UF) Precision Health Research Center in The Villages and Casana have partnered to conduct a research study titled “A Community Based Participatory Research Approach to Improving Health and Wellness for Older Adults in The Villages Comparing Remote Monitoring Device Adherence.”

Learn More

Casana Collaborates With Massachusetts General Hospital

Casana has entered into a collaboration with the Massachusetts General Hospital (MGH) Cardiovascular Disease Prevention Center (CVDPC) to conduct a research study titled “Validation of a novel toilet seat-based cuffless blood pressure measurement technology and association with left ventricular mass index” utilizing the Heart Seat.

Learn More

Casana Studies Demonstrate Shift to RPM

The COVID-19 pandemic brought about a drastic cultural shift in the way people think about healthcare, with an increased demand for in-home health options. In 2020, over 29 million patients used remote patient monitoring services and tools. Growth in remote patient monitoring peaked in April 2020, with the overall usage of office visits and outpatient care being 78 times higher than in February 2020. As more individuals seek to avoid in-person healthcare visits, whether out of comfort or necessity, the demand for in-home health options has skyrocketed. This trend is expected to continue, with an estimated $250 billion of US healthcare spend that could be shifted towards virtual or virtually enabled care.

Learn More

Casana and Cleveland Clinic Successfully Conclude Cardiac Rehab Stress Shifts Study

Casana and Cleveland Clinic Successfully Conclude Cardiac Rehab Stress Shifts Study” with body copy “By concluding the Cardiac Rehab Stress Shifts Study, Casana and Cleveland Clinic have obtained valuable data to enhance the accuracy and performance of the Heart Seat as a non-invasive cardiovascular monitoring system.

Learn More


Who can bill for the Heart Seat, and what are the requirements in order to be reimbursed for the product?

The Heart Seat can be billed by providers through existing RPM CPT codes. Casana will charge providers a monthly fee for the data.

How does the seat identify a user?

A proprietary bio-identification algorithm distinguishes individual users, only displaying health data of a designated user to the appropriate provider or care team.

How is the data transmitted securely to the provider or care team?

Data is uploaded to Casana’s secure Cloud, computing measures for the prescribed user. The clinician easily accesses data over time for their prescribed user in a simplified dashboard, or in the EMR.

When will this product be available?

Casana is currently pursuing FDA-clearance for blood pressure with the target of an initial product market launch by the end of 2023.